Skip to main content

Rebekah Watkins-Schultz (Jenny Ting lab) published an article titled “A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity” in Biomaterials (DOI: 10.1016/j.biomaterials.2019.03.011). Image: Flow cytometry to detect tumor-infiltrating leukocytes after microparticle injection; see article for details.

Please see our page on Publications by GMB Students for more.

Comments are closed.